ReviewNovel Risk Factors for Atherosclerosis
Section snippets
Homocysteine
Considerable evidence has accumulated to implicate increased plasma homocysteine levels as a risk factor for atherosclerotic vascular disease.6 Homocysteine is a thiol-containing amino acid intermediate formed during the metabolism of methionine, an essential amino acid. In healthy persons, plasma homocysteine levels are between 5 and 15 μmol/L in the fasting state.7 Increased homocysteine plasma levels have been associated with aging,8 menopause,9 chronic renal insufficiency,10 low plasma
Fibrinogen
Several studies point to the importance of fibrinogen as a risk factor for atherosclerotic vascular disease. A meta-analysis of 6 prospective epidemiological studies confirmed the association of increased fibrinogen levels with subsequent MI or stroke.35 Persons with levels in the upper tertile had a relative risk of future cardiovascular disease that was 2.3 times higher than the risk in persons with levels in the lowest tertile. Of these 6 studies, only the Framingham Study included women36,
Impaired Fibrinolysis
The fibrinolytic system consists of plasminogen, which is converted to its active form plasmin by plasminogen activators, including tPA. A. Inhibitors of the system include plasminogen activator inhibitor type 1 (PAI-1) and plasmin inhibitors such as α2 -antiplasmin. In the Northwick Park Heart Study, fibrinolytic activity was measured by dilute blood clot lysis time at study entry in 1382 men, age 40 to 64 years, of whom 179 subsequently experienced episodes of CAD during a mean follow-up of
Platelet Reactivity
Platelet size, function, and number may be related to the risk of developing atherosclerotic cardiovascular events. Cross-sectional data from the Caerphilly Collaborative Heart Disease Study, in which platelet aggregation was measured in about 2000 men with no history of recent aspirin ingestion, demonstrated that patients with CAD had a significantly greater adenosine diphosphate-induced platelet aggregation compared with controls.67 Spontaneous platelet aggregation was a useful marker for
Hypercoagulability
An interesting feature of the hypercoagulable states is that they affect various vascular beds differently.80 Despite the predisposition to venous thrombosis, congenital deficiencies of antithrombin III, protein C, and protein are not associated with an increased incidence of arterial thrombosis or CAD.81 The factor V Leiden mutation is associated with venous thrombosis but not with atherosclerotic arterial disease, except perhaps in young women who smoke.82, 83 The prothrombin gene mutation
Lipoprotein(a)
Lipoprotein(a) refers to a family of lipoprotein particles similar to LDL in core lipid composition and in having apo B-100 as a surface apolipoprotein. In addition, Lp(a) possesses a unique glycoprotein, apo(a), which is bound to apo B-100.89 Lipoprotein(a) is associated with an increased risk of premature cardiovascular disease, but its physiological role remains obscure. Plasma levels vary widely among persons (about 1000-fold) but are stable within individuals, suggesting a strong heritable
Small Dense LDL
Low-density lipoprotein particles differ in size and density and have been divided into 2 distinct phenotypes: pattern B with a predominance of small dense LDL particles and pattern A with a higher proportion of large, more buoyant LDL particles.119 Small dense LDL particles tend to coexist with increased triglycerides and low HDL-C values, a combination that has been termed atherogenic dyslipidemia.119
Several retrospective studies have suggested that pattern B is associated with an increased
C-Reactive Protein
C-reactive protein, an acute phase reactant, is a marker for underlying systemic inflammation. Several studies have established an association between CRP and various manifestations of atherosclerosis. In a cross-sectional study, levels of CRP were associated with several other vascular risk factors, including smoking, hypertension, hypercholesterolemia, obesity, and diabetes.136 Levels of CRP were increased in chronic angina and in acute coronary syndromes.137 Increased CRP levels may predict
Infectious Agents
Recently, increasing interest has centered on the infectious theory of atherosclerosis. The hypothesis was initially proposed in the first 2 decades of the 20th century,150, 151 but it was not until the study by Fabricant et al152 in 1978, demonstrating development of atherosclerosis in chickens infected with the avian herpesvirus, that interest was rekindled. Subsequently, Chlamydia pneumoniae, Helicobacter pylori, Herpesvirus hominis, and cytomegalovirus have been implicated as primary
Conclusion
Atherosclerotic vascular disease is an exceedingly common disorder whose etiology is complex and multifactorial. Identifying new risk factors for atherosclerosis is important to enhance our understanding of its etiology, improve our ability to predict risk, and facilitate development of therapeutic and preventive approaches. Although pharmacological treatment is possible for several of the novel risk factors discussed in this article, prospective trial evidence to support such an approach is
References (159)
- et al.
Apolipoproteins and ischaemic heart disease: implications for screening
Lancet
(1994) - et al.
Homocysteine and coronary atherosclerosis
J Am Coll Cardtol
(1996) - et al.
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocy sleinemia
Am J Clin Nutr
(1993) - et al.
Increase in total plasma homocysteine concentration after cardiac transplantation
Mayo Clin Proc
(1995) - et al.
Postmethionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study
Atherosclerosis
(1995) - et al.
Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
Blood
(1990) - et al.
Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents
J Am Coll Cardiol
(1993) - et al.
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
Kidney Int
(1996) Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study
Am Heart J
(1987)- et al.
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS), I: risk factors for myocardial infarction in a cohort of 5790 men
Atherosclerosis
(1997)
Genetic and cultural inheritance of plasma fibrinogen concentration
Lancet
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations
Lancet
Abstention from chronic cigarette smoking normalizes blood rheology
Atherosclerosis
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study
Am Heart J
The role of fibrinogen as a cardiovascular risk factor
Atherosclerosis
Fibrinolytic activity, clotting factors, and long-term incidence of ischeemic heart disease in the Northwick Park Heart Study
Lancet
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
Lancet
Prospective study of endogenous tissue plasminogen activator and risk of stroke
Lancet
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction
Lancet
Fibrinolysis and atherosclerosis
Baillieres Clin HaematoL
Aspirin in the primary prevention of cardiovascular disease
Cardiol Clin
Hypothesis: is soluble P-selectin a new marker of platelet activation?
Atherosclerosis
Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study
Am J Clin Nutr
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
Blood
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
Blood
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events
Lancet
Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
Am J Cardiol
Ho well can we predict coronary heart disease? findings in the United Kingdom Heart Disease Prevention Project
BMJ
Emerging epidemic of cardiovascular disease in developing countries
Circulation
Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans
Diabetologia
The changing pattern of cardiovascular diseases in China
World Health Slat Q
Total homocysteine in plasma or serum: methods and clinical applications
Clin Chem
Protein-bound homocyst(e)ine: a possible risk factor for coronary artery disease
J Clin Invest
Rapid HPLC determination of total homocysteine and other thiols in scrum and plasma: sex differences and con-elation with cobalamin and folate concentrations in healthy subjects
Clin Chem
Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
Kidney Int Suppl
Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project
JAMA
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes
JAMA
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
JAMA
Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease
Arterioscler Thromb
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
N Engl J Med
Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease
Arterioscler Thromb Vase Biol
Hyperhomocysleinemia and low pyrtdoxal phosphate: common and independent reversible risk factors for coronary artery disease
Circulation
Plasma homocysteine levels and mortality in patients with coronary artery disease
N Engl J Med
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
J Clin Invest
Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells
J Clin Invest
Homocysteine as a risk factor for vascular disease: enhanced collagen production and accumulation by smooth muscle cells
Arterioscler Thromb Vase Biol
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
J Clin Invest
Homocysteine-induced modulation of tissue plas-minogen activator binding to its endothelial cell membrane receptor
J Clin Invest
Acute melhionine load-induced hyperhomocysleinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats
FASEB J
Hyper-homocyst(e)inemia is associated with impaired endotheliumendotheliumdependent vasodilation in humans
Circulation
Cited by (159)
Pregnancy and autoimmune disease, reproductive and hormonal issues
2018, Dubois' Lupus Erythematosus and Related SyndromesReproductive and Hormonal Issues in Women with Autoimmune Diseases
2013, Dubois' Lupus Erythematosus and Related Syndromes: Eighth EditionMedical Management of the Patient with Intermittent Claudication
2011, Cardiology ClinicsButyrylcholinesterase activity in young men and women: Association with cardiovascular risk factors
2011, Clinical Biochemistry